DrugPatentWatch Database Preview
Details for Patent: 9,840,505
Email this page to a colleague
Which drugs does patent 9,840,505 protect, and when does it expire?
Patent 9,840,505 protects COPIKTRA and is included in one NDA.
This patent has thirty-eight patent family members in twenty-two countries.
Summary for Patent: 9,840,505
| Title: | Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereof |
| Abstract: | Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof. |
| Inventor(s): | Ren; Pingda (San Diego, CA), Martin; Michael (San Marcos, CA), Isbester; Paul (Castleton, NY), Lane; Benjamin S. (Lynnfield, MA), Kropp; Jason (Westford, MA) |
| Assignee: | Infinity Pharmaceuticals, Inc. (Cambridge, MA) |
| Application Number: | 15/016,117 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,840,505
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Secura | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-001 | Sep 24, 2018 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | FOR THE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA (FL) | ⤷ Try it Free | ||||
| Secura | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-001 | Sep 24, 2018 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR SMALL LYMPHOCYTIC LEUKEMIA (SLL) | ⤷ Try it Free | ||||
| Secura | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-002 | Sep 24, 2018 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR SMALL LYMPHOCYTIC LEUKEMIA (SLL) | ⤷ Try it Free | ||||
| Secura | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-002 | Sep 24, 2018 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | FOR THE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA (FL) | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,840,505
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 084824 | ⤷ Try it Free | |||
| Australia | 2012205669 | ⤷ Try it Free | |||
| Australia | 2015258280 | ⤷ Try it Free | |||
| Canada | 2824197 | ⤷ Try it Free | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
